Healthcare organizations are investing rapidly in AI and advanced analytics, yet many struggle to translate clinical data into tools that are safe, equitable, and useful in real care settings.

First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference ...

RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The folks at Penn Medicine know a little something about putting data analytics to work. After identifying three years ago that their sepsis mortality rates were higher than expected, they set out to ...

Brentwood, Tenn.-based HealthTrust Purchasing Group has acquired certain assets of Cardiac Data Solutions, an analytic platform that helps healthcare leaders improve clinical and financial outcomes, ...

The global market for clinical data analytics is expected to grow at a compound annual growth rate of 12.5 percent by 2023, according to a Market Research Future report. Clinical data analytics ...

Subject to execution of definitive agreements, the data analytics platform is expected to be initially deployed to support a Medicus-sponsored study planned for Q2-Q4 2026, with potential expansion to ...